$1.23 Billion is the total value of Rhenman & Partners Asset Management AB's 83 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 35.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABBV | Buy | ABBVIE INC | $53,575,000 | +118.5% | 500,000 | +78.6% | 4.37% | +100.4% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $44,722,000 | -21.0% | 510,000 | -31.5% | 3.65% | -27.5% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $43,890,000 | -18.7% | 600,000 | -13.7% | 3.58% | -25.4% |
| MDT | Buy | MEDTRONIC PLC | $37,485,000 | +63.4% | 320,000 | +44.9% | 3.06% | +49.9% |
| UNH | Sell | UNITED HEALTH GROUP INC | $36,821,000 | +7.4% | 105,000 | -4.5% | 3.00% | -1.5% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $36,311,000 | +49.8% | 220,000 | +29.4% | 2.96% | +37.4% |
| LLY | Buy | LILLY ELI & CO | $30,391,000 | +24.4% | 180,000 | +9.1% | 2.48% | +14.1% |
| CI | Sell | CIGNA CORP NEW | $29,145,000 | +14.7% | 140,000 | -6.7% | 2.38% | +5.2% |
| CVS | Buy | CVS HEALTH CORP | $28,686,000 | +104.7% | 420,000 | +75.0% | 2.34% | +87.8% |
| MRK | Buy | MERCK & CO INC | $28,141,000 | +112.0% | 344,020 | +115.0% | 2.30% | +94.6% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $27,179,000 | -9.2% | 115,000 | +4.5% | 2.22% | -16.7% |
| ANTM | Sell | ANTHEM INC | $25,687,000 | +6.3% | 80,000 | -11.1% | 2.10% | -2.5% |
| HUM | Sell | HUMANA INC | $23,796,000 | -4.2% | 58,000 | -3.3% | 1.94% | -12.1% |
| TDOC | New | TELADOC HEALTH INC | $22,995,000 | – | 115,000 | +100.0% | 1.88% | – |
| AXNX | AXONICS MODULATION TECH INC | $22,963,000 | -2.2% | 460,000 | 0.0% | 1.87% | -10.3% | |
| NKTR | Buy | NEKTAR THERAPEUTICS | $22,950,000 | +38.3% | 1,350,000 | +35.0% | 1.87% | +26.9% |
| GILD | Buy | GILEAD SCIENCES INC | $22,430,000 | +22.4% | 385,000 | +32.8% | 1.83% | +12.3% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $21,964,000 | +15.7% | 100,000 | -12.5% | 1.79% | +6.2% |
| GH | Sell | GUARDANT HEALTH INC | $21,910,000 | -18.3% | 170,000 | -29.2% | 1.79% | -25.0% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $21,090,000 | +20.6% | 340,000 | +17.2% | 1.72% | +10.7% |
| NVCR | Sell | NOVOCURE LTD | $20,765,000 | -54.5% | 120,000 | -70.7% | 1.69% | -58.2% |
| XLRN | Buy | ACCELERON PHARMA INC | $20,470,000 | +25.5% | 160,000 | +10.3% | 1.67% | +15.1% |
| ABMD | Sell | ABIOMED INC | $20,425,000 | +5.3% | 63,000 | -10.0% | 1.67% | -3.4% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $20,142,000 | -0.1% | 235,000 | -24.2% | 1.64% | -8.3% |
| COO | Sell | COOPER COS INC | $19,983,000 | -1.2% | 55,000 | -8.3% | 1.63% | -9.4% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $19,324,000 | +53.4% | 40,000 | +77.8% | 1.58% | +40.8% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $19,054,000 | +10.8% | 530,000 | +17.8% | 1.56% | +1.7% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $18,749,000 | -25.5% | 120,000 | -45.5% | 1.53% | -31.6% |
| JNJ | New | JOHNSON & JOHNSON | $18,099,000 | – | 115,000 | +100.0% | 1.48% | – |
| CNC | Sell | CENTENE CORP DEL | $17,109,000 | -2.2% | 285,000 | -5.0% | 1.40% | -10.3% |
| BAX | Buy | BAXTER INTL INC | $16,449,000 | +32.0% | 205,000 | +32.3% | 1.34% | +21.1% |
| ABT | Sell | ABBOTT LABS | $16,424,000 | -26.4% | 150,000 | -26.8% | 1.34% | -32.5% |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $15,900,000 | +30.4% | 500,000 | +5.3% | 1.30% | +19.6% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $15,444,000 | +127.5% | 270,000 | +20.0% | 1.26% | +108.6% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $15,398,000 | -9.0% | 592,225 | +30.2% | 1.26% | -16.5% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $14,848,000 | +32.7% | 320,000 | -5.9% | 1.21% | +21.7% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $14,518,000 | -0.3% | 111,700 | +11.7% | 1.18% | -8.6% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $14,378,000 | +99.4% | 150,000 | +100.0% | 1.17% | +83.0% |
| MGNX | Sell | MACROGENICS INC | $14,288,000 | -10.8% | 625,000 | -1.7% | 1.17% | -18.1% |
| SGMO | Buy | SANGAMO THERAPEUTICS INC | $12,826,000 | +101.1% | 821,888 | +21.8% | 1.05% | +84.5% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $12,786,000 | -3.5% | 27,450 | -8.5% | 1.04% | -11.5% |
| LIVN | Sell | LIVANOVA PLC | $12,580,000 | +32.5% | 190,000 | -9.5% | 1.03% | +21.6% |
| RPRX | New | ROYALTY PHARMA PLC | $12,513,000 | – | 250,000 | +100.0% | 1.02% | – |
| HCA | HCA HEALTHCARE INC | $12,335,000 | +31.9% | 75,000 | 0.0% | 1.01% | +21.1% | |
| AERI | AERIE PHARMACEUTICALS INC | $11,484,000 | +14.8% | 850,000 | 0.0% | 0.94% | +5.3% | |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $11,404,000 | +19.1% | 125,000 | +4.2% | 0.93% | +9.2% |
| SGEN | New | SEAGEN INC | $11,384,000 | – | 65,000 | +100.0% | 0.93% | – |
| XNCR | Sell | XENCOR INC | $11,315,000 | +12.2% | 259,341 | -0.3% | 0.92% | +2.9% |
| BDX | Buy | BECTON DICKINSON & CO | $11,260,000 | +38.3% | 45,000 | +28.6% | 0.92% | +26.9% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $10,016,000 | -10.3% | 65,000 | -20.7% | 0.82% | -17.7% |
| EXAS | Sell | EXACT SCIENCES CORP | $9,937,000 | +21.8% | 75,000 | -6.2% | 0.81% | +11.9% |
| BIIB | Buy | BIOGEN INC | $9,794,000 | +4.6% | 40,000 | +21.2% | 0.80% | -4.0% |
| GKOS | Sell | GLAUKOS CORP | $9,408,000 | +35.7% | 125,000 | -10.7% | 0.77% | +24.7% |
| RDUS | Buy | RADIUS HEALTH INC | $8,605,000 | +128.7% | 481,826 | +45.2% | 0.70% | +109.6% |
| SILK | Sell | SILK ROAD MEDICAL INC | $7,873,000 | -16.3% | 125,000 | -10.7% | 0.64% | -23.3% |
| MGTX | Buy | MEIRAGTX HOLDINGS PLC | $6,813,000 | +37.2% | 450,000 | +20.0% | 0.56% | +26.1% |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $6,775,000 | +5.2% | 625,000 | 0.0% | 0.55% | -3.3% | |
| ACCD | Sell | ACCOLADE INC | $6,525,000 | +10.7% | 150,000 | -1.1% | 0.53% | +1.5% |
| RVNC | REVANCE THERAPEUTICS INC | $6,235,000 | +12.7% | 220,000 | 0.0% | 0.51% | +3.5% | |
| SWAV | SHOCKWAVE MEDICAL INC | $6,223,000 | +36.8% | 60,000 | 0.0% | 0.51% | +25.7% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $6,077,000 | +45.8% | 1,736,176 | 0.0% | 0.50% | +33.7% | |
| PHAT | New | PHATHOM PHARMACEUTICALS INC | $5,814,000 | – | 175,000 | +100.0% | 0.47% | – |
| ISRG | Sell | INTUITIVE SURGICAL INC | $5,727,000 | -32.7% | 7,000 | -41.7% | 0.47% | -38.3% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $5,633,000 | +78.8% | 130,000 | +44.4% | 0.46% | +64.3% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $5,524,000 | +3.5% | 200,000 | -47.4% | 0.45% | -5.1% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $5,378,000 | -65.9% | 70,000 | -66.8% | 0.44% | -68.7% |
| FGEN | FIBROGEN INC | $5,378,000 | -9.8% | 145,000 | 0.0% | 0.44% | -17.2% | |
| GTHX | Buy | G1 THERAPEUTICS INC | $4,318,000 | +96.7% | 240,000 | +26.3% | 0.35% | +80.5% |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $4,253,000 | – | 250,000 | +100.0% | 0.35% | – |
| ALKS | Sell | ALKERMES PLC | $4,177,000 | -18.7% | 209,354 | -32.5% | 0.34% | -25.4% |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $4,119,000 | +3.0% | 925,534 | 0.0% | 0.34% | -5.4% | |
| OSH | New | OAK STR HEALTH INC | $3,670,000 | – | 60,000 | +100.0% | 0.30% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS INC | $3,424,000 | – | 60,000 | +100.0% | 0.28% | – |
| ANNX | New | ANNEXON INC | $3,254,000 | – | 130,000 | +100.0% | 0.26% | – |
| VRAY | VIEWRAY INC | $2,961,000 | +9.1% | 775,000 | 0.0% | 0.24% | +0.4% | |
| EPZM | EPIZYME INC | $2,878,000 | -9.0% | 265,000 | 0.0% | 0.24% | -16.4% | |
| STXS | New | STEREOTAXIS INC | $2,873,000 | – | 564,400 | +100.0% | 0.23% | – |
| EPIX | New | ESSA PHARMA INC | $1,869,000 | – | 156,700 | +100.0% | 0.15% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $1,729,000 | – | 125,000 | +100.0% | 0.14% | – |
| AMWL | New | AMERICAN WELL CORPcl a | $1,520,000 | – | 60,000 | +100.0% | 0.12% | – |
| GDRX | New | GOODRX HLDGS INC | $1,412,000 | – | 35,000 | +100.0% | 0.12% | – |
| CTIC | New | CTI BIOPHARMA CORP | $966,000 | – | 300,000 | +100.0% | 0.08% | – |
| PIRS | PIERIS PHARMACEUTICALS INC | $750,000 | +20.8% | 300,000 | 0.0% | 0.06% | +10.9% | |
| F | Exit | FORD MTR CO DEL | $0 | – | -29,164 | -100.0% | -0.02% | – |
| CVX | Exit | CHEVRON CORP | $0 | – | -2,974 | -100.0% | -0.02% | – |
| QCOM | Exit | QUALCOMM INC | $0 | – | -2,381 | -100.0% | -0.02% | – |
| ABEO | Exit | ABEONA THERAPEUTICS INC | $0 | – | -925,000 | -100.0% | -0.08% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -300,000 | -100.0% | -0.11% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -40,466 | -100.0% | -0.13% | – |
| CLLS | Exit | CELLECTIS S Aspons ads | $0 | – | -144,604 | -100.0% | -0.24% | – |
| INCY | Exit | INCYTE CORP LTD | $0 | – | -40,000 | -100.0% | -0.32% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL INC | $0 | – | -61,500 | -100.0% | -0.45% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -107,797 | -100.0% | -0.52% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -70,000 | -100.0% | -1.22% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -221,351 | -100.0% | -1.67% | – |
| LVGO | Exit | LIVONGO HEALTH INC | $0 | – | -166,961 | -100.0% | -2.08% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -190,000 | -100.0% | -2.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-01-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.